Bleeding risk with concomitant use of tirofiban and third-generation P2Y12 receptor antagonists in patients with acute myocardial infarction: A real-life data

Bleeding risk with concomitant use of tirofiban and third-generation P2Y12 receptor antagonists in patients with acute myocardial infarction: A real-life data

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Mustafa Kürşat Tigen, Mehmet Hasan Özdil, Altuğ Çinçin, Emre Gürel, Murat Sünbül, Anıl Şahin, Tuba Güçtekin, Zekeriya Doğan, Nurten Sayar, Beste Özben
Format: article
Langue:EN
Publié: KARE Publishing 2021
Sujets:
Diseases of the circulatory (Cardiovascular) system
RC666-701
Accès en ligne:https://doaj.org/article/c8642e439ea24e6da95ee587a831158f
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
id oai:doaj.org-article:c8642e439ea24e6da95ee587a831158f
record_format dspace
spelling oai:doaj.org-article:c8642e439ea24e6da95ee587a831158f2021-11-07T13:56:01ZBleeding risk with concomitant use of tirofiban and third-generation P2Y12 receptor antagonists in patients with acute myocardial infarction: A real-life data10.5152/AnatolJCardiol.2021.279742149-22632149-2271https://doaj.org/article/c8642e439ea24e6da95ee587a831158f2021-10-01T00:00:00Zhttps://anatoljcardiol.com/jvi.aspx?un=AJC-27974&volume=25&issue=10https://doaj.org/toc/2149-2263https://doaj.org/toc/2149-2271Mustafa Kürşat TigenMehmet Hasan ÖzdilAltuğ ÇinçinEmre GürelMurat SünbülAnıl ŞahinTuba GüçtekinZekeriya DoğanNurten SayarBeste ÖzbenKARE PublishingarticleDiseases of the circulatory (Cardiovascular) systemRC666-701ENAnatolian Journal of Cardiology, Vol 25, Iss 10, Pp 699-705 (2021)
institution DOAJ
collection DOAJ
language EN
topic Diseases of the circulatory (Cardiovascular) system
RC666-701
spellingShingle Diseases of the circulatory (Cardiovascular) system
RC666-701
Mustafa Kürşat Tigen
Mehmet Hasan Özdil
Altuğ Çinçin
Emre Gürel
Murat Sünbül
Anıl Şahin
Tuba Güçtekin
Zekeriya Doğan
Nurten Sayar
Beste Özben
Bleeding risk with concomitant use of tirofiban and third-generation P2Y12 receptor antagonists in patients with acute myocardial infarction: A real-life data
format article
author Mustafa Kürşat Tigen
Mehmet Hasan Özdil
Altuğ Çinçin
Emre Gürel
Murat Sünbül
Anıl Şahin
Tuba Güçtekin
Zekeriya Doğan
Nurten Sayar
Beste Özben
author_facet Mustafa Kürşat Tigen
Mehmet Hasan Özdil
Altuğ Çinçin
Emre Gürel
Murat Sünbül
Anıl Şahin
Tuba Güçtekin
Zekeriya Doğan
Nurten Sayar
Beste Özben
author_sort Mustafa Kürşat Tigen
title Bleeding risk with concomitant use of tirofiban and third-generation P2Y12 receptor antagonists in patients with acute myocardial infarction: A real-life data
title_short Bleeding risk with concomitant use of tirofiban and third-generation P2Y12 receptor antagonists in patients with acute myocardial infarction: A real-life data
title_full Bleeding risk with concomitant use of tirofiban and third-generation P2Y12 receptor antagonists in patients with acute myocardial infarction: A real-life data
title_fullStr Bleeding risk with concomitant use of tirofiban and third-generation P2Y12 receptor antagonists in patients with acute myocardial infarction: A real-life data
title_full_unstemmed Bleeding risk with concomitant use of tirofiban and third-generation P2Y12 receptor antagonists in patients with acute myocardial infarction: A real-life data
title_sort bleeding risk with concomitant use of tirofiban and third-generation p2y12 receptor antagonists in patients with acute myocardial infarction: a real-life data
publisher KARE Publishing
publishDate 2021
url https://doaj.org/article/c8642e439ea24e6da95ee587a831158f
work_keys_str_mv AT mustafakursattigen bleedingriskwithconcomitantuseoftirofibanandthirdgenerationp2y12receptorantagonistsinpatientswithacutemyocardialinfarctionareallifedata
AT mehmethasanozdil bleedingriskwithconcomitantuseoftirofibanandthirdgenerationp2y12receptorantagonistsinpatientswithacutemyocardialinfarctionareallifedata
AT altugcincin bleedingriskwithconcomitantuseoftirofibanandthirdgenerationp2y12receptorantagonistsinpatientswithacutemyocardialinfarctionareallifedata
AT emregurel bleedingriskwithconcomitantuseoftirofibanandthirdgenerationp2y12receptorantagonistsinpatientswithacutemyocardialinfarctionareallifedata
AT muratsunbul bleedingriskwithconcomitantuseoftirofibanandthirdgenerationp2y12receptorantagonistsinpatientswithacutemyocardialinfarctionareallifedata
AT anılsahin bleedingriskwithconcomitantuseoftirofibanandthirdgenerationp2y12receptorantagonistsinpatientswithacutemyocardialinfarctionareallifedata
AT tubaguctekin bleedingriskwithconcomitantuseoftirofibanandthirdgenerationp2y12receptorantagonistsinpatientswithacutemyocardialinfarctionareallifedata
AT zekeriyadogan bleedingriskwithconcomitantuseoftirofibanandthirdgenerationp2y12receptorantagonistsinpatientswithacutemyocardialinfarctionareallifedata
AT nurtensayar bleedingriskwithconcomitantuseoftirofibanandthirdgenerationp2y12receptorantagonistsinpatientswithacutemyocardialinfarctionareallifedata
AT besteozben bleedingriskwithconcomitantuseoftirofibanandthirdgenerationp2y12receptorantagonistsinpatientswithacutemyocardialinfarctionareallifedata
_version_ 1718443448460115968

Documents similaires